The development of MSCopilot® supported by the Innov'up Leader PIA Program of the Ile-de-France Region

August 13, 2020

The development of MSCopilot® has been selected to benefit from innovation aid under the Innov'up Leader PIA scheme, jointly funded by the State and the Ile-de-France Regional Council and operated by Bpifrance.

This program will allow Ad Scientiam to continue accelerating the development of MSCopilot®, a CE marked software medical device for the self-assessment of patients with Multiple Sclerosis (MS), in real life.

Share

MSCopilot®: New clinical results confirm central role of digital biomarkers in the monitoring of patients with multiple sclerosis Our news
en_USEnglish